Ona Therapeutics Secures $86.6 Million in Latest Series B Funding Round

Ona Therapeutics secured $86.6 million in its latest Series B, adding another data point to the Healthcare & Life Sciences funding market.

Ona Therapeutics Raises $86.6 million in Funding

Ona Therapeutics bags $86.6m Series B for stealth ADC push is a m Series B for stealth ADC push - European Biotechnology Magazine. Barcelona-based Digital Health company focused on advance its antibody-drug conjugates into clinical trials.

Investors Behind the Funding

The round was backed by ONA-255. Funding Intelligence tracks this investor activity alongside sector momentum, co-investor patterns, and recent comparable raises.

Company Profile and Market Context

Ona Therapeutics operates in Healthcare & Life Sciences. Ona Therapeutics bags $86.6m Series B for stealth ADC push's Series B round shows investors are still backing digital health platforms with real scale narratives. At $87M, the deal suggests buyers want category leaders that can turn AI, automation, or workflow leverage into durable enterprise demand.

Strategic Use of Funds

advance its antibody-drug conjugates into clinical trials

Looking Ahead

Ona Therapeutics bags $86.6m Series B for stealth ADC push

Source reference: original announcement/article.